Fas gene promoter -670 polymorphism (A/G) is associated with cervical carcinogenesis

Gynecologic Oncology

Volumn 98, Issue 1, 2005, Pages 129-133

  Ueda, Masatsugu ^a   Hung, Yao Ching ^b   Terai, Yoshito ^a   Yamaguchi, Hiroyuki ^a   Saito, Junko ^c   Nunobiki, Osamu ^d   Noda, Sadamu ^d   Ueki, Minoru ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c KANSAI MEDICAL UNIVERSITY   (Japan)

^d Osaka Cancer Prev Detection Ctr   (Japan)

Author keywords

Cervical carcinogenesis; Fas; Polymorphism; SIL

Indexed keywords

FAS ANTIGEN;

ARTICLE; CANCER CELL CULTURE; CANCER GRADING; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENOTYPE; HIGH RISK PATIENT; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VIRUS CARCINOGENESIS; WART VIRUS;

ANTIGENS, CD95; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); UTERINE CERVICAL NEOPLASMS;

EID: 20444483608     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.04.001     Document Type: Article

References (28)

1. H. zur Hausen Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis J. Natl. Cancer. Inst. 92 2000 690 698
2. H.M. Lorenz, M. Herrmann, T. Winkler, U. Gaipl, and J.R. Kalden Role of apoptosis in autoimmunity Apoptosis 5 2000 443 449
3. M. Zornig, A. Hueber, W. Baum, and G. Evan Apoptosis regulators and their role in tumorigenesis Biochim. Biophys. Acta 1551 2001 F1 F37
4. S. Nagata Apoptosis by death factor Cell 88 1997 355 365
5. L.M. Butler, P.J. Hewett, W.J. Butler, and P.A. Cowled Down-regulation of Fas gene expression in colon cancer is not a result of allelic loss or gene rearrangement Br. J. Cancer 77 1998 1454 1459
6. S.H. Lee, M.S. Shin, W.S. Park, S.Y. Kim, S.M. Dong, and J.H. Pi Alterations of Fas (APO-1/CD95) gene in transitional cell carcinomas of urinary bladder Cancer Res. 59 1999 3068 3072
7. T. Shimonishi, K. Isse, F. Shibata, I. Aburatani, K. Tsuneyama, and H. Sabit Up-regulation of fas ligand at early stages and down-regulation of Fas at progressed stages of intrahepatic cholangiocarcinoma reflect evasion from immune surveillance Hepatology 32 2000 761 769
8. F. Rudert, E. Visser, L. Forbes, E. Lindridge, Y. Wang, and J. Watson Identification of a silencer, enhancer, and basal promoter region in the human CD95 (Fas/APO-1) gene DNA Cell Biol. 14 1995 931 937
9. S. Kanemitsu, K. Ihara, A. Saifddin, T. Otsuka, T. Takeuchi, and J. Nagayama A functional polymorphism in fas (CD95/APO-1) gene promoter associated with systemic lupus erythematosus J. Rheumatol. 29 2002 1183 1188
10. Q.R. Huang, V. Danis, M. Lassere, J. Edmonds, and N. Manolios Evaluation of a new Apo-1/Fas promoter polymorphism in rheumatoid arthritis and systemic lupus erythematosus patients Rheumatology (Oxford) 38 1999 645 651
11. Y.H. Lee, Y.R. Kim, J.D. Ji, J. Sohn, and G.G. Song Fas promoter -670 polymorphism is associated with development of anti-RNP antibodies in systemic lupus erythematosus J. Rheumatol. 28 2001 2008 2011
12. H.C. Lai, H.K. Sytwu, C.A. Sun, M.H. Yu, C.P. Yu, and H.S. Liu Single nucleotide polymorphism at Fas promoter is associated with cervical carcinogenesis Int. J. Cancer 103 2003 221 225
13. F. Basolo, R. Giannini, P. Faviana, G. Fontanini, A. Patricelli Malizia, and C. Ugolini Thyroid papillary carcinoma: preliminary evidence for a germ-line single nucleotide polymorphism in the Fas gene J. Endocrinol. 182 2004 479 484
14. M. Ueda, M. Ueki, T. Yamada, Y. Okamoto, T. Maeda, and O. Sugimoto Scatchard analysis of EGF receptor and effects of EGF on growth and TA-4 production of newly established uterine cervical cancer cell line (OMC-1) Hum. Cell 2 1989 401 410
15. S. Taguchi Establishment and characterization of the human uterine cervical epidermoid cancer cell line Acta Obstet. Gynecol. Jpn. 33 1981 1180 1188
16. I. Ishiwata, S. Nozawa, K. Kiguchi, S. Kurihara, and H. Okumura Establishment of human uterine cervical cancer cell line and comparative studies between normal and malignant uterine cervical cells in vitro Acta Obstet. Gynaecol. Jpn. 30 1978 731 738
17. S. Nozawa, Y. Udagawa, H. Ohta, S. Kurihara, and W.H. Fishman Newly established uterine cervical cancer cell line (SKG-III) with Regan isoenzyme, human chorionic gonadotropin β-subunit, and pregnancy-specific β1-glycoprotein phenotypes Cancer Res. 43 1983 1748 1760
18. A. Mitsuhashi, H. Tanaka, N. Tanaka, M. Sugita, H. Shirasawa, and H. Tokita Establishment and characterization of a new HPV-negative squamous cell carcinoma cell line (Yumoto) from the human uterine cervix Gynecol. Oncol. 70 1998 339 347
19. H. Shirasawa, Y. Tomita, A. Fuse, T. Yamamoto, H. Tanzawa, and S. Sekiya Structure and expression of an integrated human papillomavirus type 16 genome amplified in a cervical carcinoma cell line J. Gen. Virol. 70 1989 1913 1919
20. M. Ueda, R.M. Gemmill, J. West, R. Winn, M. Sugita, and N. Tanaka Mutations of the β- and γ-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas Br. J. Cancer 85 2001 64 68
21. H. Nagano, H. Yoshikawa, T. Kawana, H. Yokota, Y. Taketani, and H. Igarashi Association of multiple human papillomavirus types with vulvar neoplasias J. Obstet. Gynecol. Res. 22 1996 1 8
22. H. Yoshikawa, T. Kawana, K. Kitagawa, M. Mizuno, H. Yoshikura, and A. Iwamoto Detection and typing of multiple genital human papillomaviruses by DNA amplification with consensus primers Jpn. J. Cancer Res. 82 1991 524 531
23. Q.R. Huang, D. Morris, and N. Manolios Identification and characterization of polymorphisms in the promoter region of the human Apo-1/Fas (CD95) gene Mol. Immunol. 34 1997 577 582
24. M.T. Engelmark, K.Y. Renkema, and U.B. Gyllensten No evidence of the involvement of the Fas -670 promoter polymorphism in cervical cancer in situ Int. J. Cancer 112 2004 1084 1085
25. A. Dybikowska, W. Sliwinski, J. Emerich, and A.J. Podhajska Evaluation of Fas gene promoter polymorphism in cervical cancer patients Int. J. Mol. Med. 14 2004 475 478
26. K. Sayama, S. Yonehara, Y. Watanabe, and Y. Miki Expression of Fas antigen on keratinocytes in vivo and induction of apoptosis in cultured keratinocytes J. Invest. Dermatol. 103 1994 330 334
27. D.N. Contreras, P.H. Krammer, R.K. Potkul, P. Bu, J.L. Rossi, and A.M. Kaufmann Cervical cancer cells induce apoptosis of cytotoxic T lymphocytes J. Immunother. 23 2000 67 74
28. H. Das, T. Koizumi, T. Sugimoto, S. Chakraborty, T. Ichimura, and K. Hasegawa Quantitation of Fas and Fas ligand gene expression in human ovarian, cervical and endometrial carcinomas using real-time quantitative RT-PCR Br. J. Cancer 82 2000 1682 1688